No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Cue Biopharma First Quarter 2024 Earnings: Beats Expectations
Express News | Cue Biopharma Shares Are Trading Lower. The Company Reported Q1 Financial Results
Oppenheimer Reaffirms Their Buy Rating on Cue Biopharma (CUE)
Express News | Cue Biopharma Inc - Expect Current Cash and Cash Equivalents to Fund Ops Into First Qtr of 2025
Cue Biopharma | 10-Q: Quarterly report
Express News | Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights